METASTATIC SOLID TUMORS
Clinical trials for METASTATIC SOLID TUMORS explained in plain language.
Never miss a new study
Get alerted when new METASTATIC SOLID TUMORS trials appear
Sign up with your email to follow new studies for METASTATIC SOLID TUMORS, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Can your own immune cells fight advanced cancer?
⭐️ CURE ⭐️ Not yet recruitingThis trial is testing an experimental therapy called IOV-5001, which uses a patient's own immune cells (tumor-infiltrating lymphocytes) to attack cancer. The study involves adults with advanced solid tumors, including non-small cell lung cancer, triple-negative breast cancer, col…
Matched conditions: METASTATIC SOLID TUMORS
Phase: PHASE1, PHASE2 • Sponsor: Iovance Biotherapeutics, Inc. • Aim: ⭐️ CURE ⭐️
Last updated Aug 08, 2026 00:03 UTC
-
Can a new infusion drug shrink Hard-to-Treat tumors?
Disease control Not yet recruitingThis early-stage trial is testing an investigational drug called SM2275 in people with advanced or metastatic solid tumors that have progressed after standard treatment or for which no standard therapy exists. The study aims to find the safest dose, understand how the drug behave…
Matched conditions: METASTATIC SOLID TUMORS
Phase: PHASE1 • Sponsor: Beijing StarMab Biomed Technology Ltd • Aim: Disease control
Last updated Aug 08, 2026 00:03 UTC
-
Blood test may let cancer patients take safe breaks from immunotherapy
Disease control Not yet recruitingThis trial investigates whether a sensitive blood test (Signatera) can detect when it is safe to pause immunotherapy in people with advanced solid tumors like lung cancer, melanoma, and colorectal cancer. Participants are randomly assigned to either continuous standard immunother…
Matched conditions: METASTATIC SOLID TUMORS
Phase: NA • Sponsor: Natera, Inc. • Aim: Disease control
Last updated Aug 06, 2026 00:00 UTC
-
New drug QLS5308 enters human testing for advanced cancers
Disease control Not yet recruitingThis early-phase study tests a new drug called QLS5308 in about 192 adults with advanced solid tumors that have spread and cannot be removed by surgery or radiation. The main goals are to check the drug's safety, find the best dose, and see if it can shrink tumors. Participants m…
Matched conditions: METASTATIC SOLID TUMORS
Phase: PHASE1 • Sponsor: Qilu Pharmaceutical Co., Ltd. • Aim: Disease control
Last updated Jun 27, 2026 11:00 UTC
-
Radioactive seeds aim to boost tumor control in patients with 6-10 metastases
Disease control Not yet recruitingThis phase 2 trial tests whether adding image-guided radioactive seed implants to standard cancer therapy can improve disease control in patients with 6 to 10 metastatic tumors. About 120 adults with solid tumors that have spread will be randomly assigned to receive either standa…
Matched conditions: METASTATIC SOLID TUMORS
Phase: PHASE2 • Sponsor: Li Min • Aim: Disease control
Last updated Jun 27, 2026 08:10 UTC
-
New hope for rare cancers: china launches massive drug trial
Disease control Not yet recruitingThis study tests several new anti-cancer drugs and technologies in 600 people with rare solid tumors that have spread or cannot be removed. Participants will receive treatments matched to their tumor's unique genetic profile. The goal is to see if these therapies are safe and shr…
Matched conditions: METASTATIC SOLID TUMORS
Phase: PHASE1, PHASE2 • Sponsor: Cancer Institute and Hospital, Chinese Academy of Medical Sciences • Aim: Disease control
Last updated Jun 27, 2026 08:07 UTC
-
New combo therapy aims to shrink Hard-to-Treat tumors
Disease control Not yet recruitingThis study tests a new drug combination (QLC5513 plus QL1706, with or without platinum chemo) in people with advanced solid tumors that have spread. The goal is to see if the treatment can shrink tumors and to check its safety. About 290 participants will take part, and the study…
Matched conditions: METASTATIC SOLID TUMORS
Phase: PHASE1, PHASE2 • Sponsor: Qilu Pharmaceutical Co., Ltd. • Aim: Disease control
Last updated Jun 27, 2026 08:03 UTC
-
New radioactive drug aims to halt bone metastases in advanced cancers
Disease control Not yet recruitingThis clinical trial tests a new drug called BPR-6023021, which is a radioactive compound designed to target bone. It is for people with advanced solid tumors that have spread to the bone and who have no other standard treatment options. The study will enroll 195 participants to e…
Matched conditions: METASTATIC SOLID TUMORS
Phase: PHASE1, PHASE2 • Sponsor: Chengdu Syncor Pharmaceutical Co., Ltd. • Aim: Disease control
Last updated Jun 27, 2026 07:59 UTC